Table 1.
Burden results for most significant annotation categories from CWAS.
| Variant type | Most significant categories within level of analysis | Variants per child (adjusted) |
Relative risk |
p-value uncorrected |
Number of comparisons |
p-value corrected |
|---|---|---|---|---|---|---|
| Cases – lowest p-value per cluster in CWAS for top five clusters | ||||||
| De novo indels | Conserved indels near protein coding genes within chromatin state 5 (Weak transcription) regions (Cluster 72) | 0.05 | 2.93 | 0.0002 | 4,123 | 0.66 |
| De novo SNVs | Conserved coding SNVs within post synaptic density genes (Cluster 91) | 0.06 | 2.63 | 0.0002 | 4,123 | 0.82 |
| De novo indels | Conserved intronic indels within chromatin state 15 (Quiescent) regions (Cluster 107) | 0.03 | 5.00 | 0.0002 | 4,123 | 0.91 |
| De novo SNVs | Intergenic SNVs near lincRNAs underlying H3K36me3 (Elongating) peaks (Cluster 58) | 4.69 | 1.11 | 0.0003 | 4,123 | 1.00 |
| De novo SNVs and indels | Conserved coding variants in post synaptic density genes within chromatin state 6 (Genic enhancer) regions (Cluster 23) | 0.01 | Inf | 0.0005 | 4,123 | 1.00 |
| Controls – lowest p-value per cluster in CWAS for top five clusters | ||||||
| De novo SNVs | Noncoding SNVs near constrained genes within chromatin state 6 (Genic enhancer) regions (Cluster 175) | 0.47 | 1.36 | 0.0002 | 4,123 | 0.70 |
| De novo SNVs | Intergenic SNVs near pseudogenes underlying H3K9me3 (Constitutive repression) peaks (Cluster 199) | 0.41 | 1.44 | 0.0002 | 4,123 | 0.78 |
| De novo SNVs | Intronic SNVs in constrained genes within chromatin state 5 (Weak transcription) regions (Cluster 75) | 6.04 | 1.09 | 0.0002 | 4,123 | 0.78 |
| De novo SNVs | Noncoding SNVs near constrained genes within chromatin state 5 (Weak transcription) regions (Cluster 20) | 7.10 | 1.07 | 0.001 | 4,123 | 1.00 |
| De novo SNVs and indels | Intergenic variants near genes co-expressed in midfetal brain within chromatin state 5 (Weak transcription) regions (Cluster 121) | 0.08 | 1.86 | 0.004 | 4,123 | 1.00 |
De novo SNVs and indels from n=519 cases and n=519 controls were compared using a case-control label-swapping permutation analysis as described in Results. P-values were Bonferroni-corrected for 4,123 effective tests.